Drugs / 251154
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01110044 | Apr 2010 → Aug 2012 | Rotavirus infection | GlaxoSmithKline | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 251154 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110044 ↗ |
| Modality | Vaccine | “The purpose of the study is to evaluate the safety and immunogenicity of a birth dose of GSK Biologicals' reduced-antigen-content tri-component pertussis (251154) vaccine...” NCT01110044 ↗ |
| Route | Intramuscular | “Intramuscular, single dose” NCT01110044 ↗ |